Colforsin

coagulation factor II, thrombin ; Homo sapiens







42 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32552955 [Effect of Protein Kinase A Activation on Aggregation Function of Platelets]. 2020 Jun 1
2 20202976 cAMP/PKA antagonizes thrombin-induced inactivation of endothelial myosin light chain phosphatase: role of CPI-17. 2010 Jul 15 1
3 19268649 Role of cAMP-dependent protein kinase in the regulation of platelet procoagulant activity. 2009 May 1 2
4 18569866 Phospholipase D activity in human platelets is inhibited by protein kinase A, involving inhibition of phospholipase D1 translocation. 2008 Jun 2
5 18586956 TIMAP is a positive regulator of pulmonary endothelial barrier function. 2008 Sep 2
6 17472573 Fluvastatin inhibits regulated secretion of endothelial cell von Willebrand factor in response to diverse secretagogues. 2007 Aug 1 1
7 17704206 Differential regulation of endothelial cell permeability by cGMP via phosphodiesterases 2 and 3. 2007 Oct 12 1
8 15543559 Adenylyl cyclase-cAMP system inhibits thrombin-induced HSP27 in vascular smooth muscle cells. 2005 Feb 15 2
9 15886804 P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets. 2005 May 1
10 16055445 Myosin phosphatase and cofilin mediate cAMP/cAMP-dependent protein kinase-induced decline in endothelial cell isometric tension and myosin II regulatory light chain phosphorylation. 2005 Sep 23 1
11 15246972 cAMP targeting of p38 MAP kinase inhibits thrombin-induced NF-kappaB activation and ICAM-1 expression in endothelial cells. 2004 Nov 2
12 12574812 Differential regulation of P-selectin expression by protein kinase A and protein kinase G in thrombin-stimulated human platelets. 2003 Feb 1
13 12588708 PKA inhibits RhoA activation: a protection mechanism against endothelial barrier dysfunction. 2003 Jun 1
14 12609843 Evidence for a role for Galphai1 in mediating weak agonist-induced platelet aggregation in human platelets: reduced Galphai1 expression and defective Gi signaling in the platelets of a patient with a chronic bleeding disorder. 2003 Jun 15 1
15 11323002 Inhibition of platelet aggregation and the release of P-selectin from platelets by cilostazol. 2001 Mar 15 1
16 10484345 Expression of PKA inhibitor (PKI) gene abolishes cAMP-mediated protection to endothelial barrier dysfunction. 1999 Sep 1
17 9539153 Autocrine regulation of endothelial exocytosis: von Willebrand factor release is induced by prostacyclin in cultured endothelial cells. 1998 Mar 13 1
18 9609742 cAMP protects endothelial barrier function independent of inhibiting MLC20-dependent tension development. 1998 Jun 1
19 9795233 Elevation of cyclic AMP decreases phosphoinositide turnover and inhibits thrombin-induced secretion in human platelets. 1998 Nov 2 1
20 14517385 On the mechanism of thrombin-induced angiogenesis: inhibition of attachment of endothelial cells on basement membrane components. 1998 2
21 8621441 The seven-transmembrane-spanning receptors for endothelin and thrombin cause proliferation of airway smooth muscle cells and activation of the extracellular regulated kinase and c-Jun NH2-terminal kinase groups of mitogen-activated protein kinases. 1996 Mar 8 1
22 8702835 Cyclic AMP inhibition of thrombin-induced growth in vascular smooth muscle cells correlates with decreased JNK1 activity and c-Jun expression. 1996 Aug 23 4
23 8880128 Different fibrinolytic potentials between human umbilical vein endothelial cells and human adult vein endothelial cells. 1996 1
24 8954139 Protein kinase C plays a key role in the cross-talk between intracellular signalings via prostanoid receptors in a megakaryoblastic cell line, MEG-01s. 1996 Nov 22 2
25 7842460 Myocardial ischaemia induces platelet activation with adverse electrophysiological and arrhythmogenic effects. 1994 Nov 1
26 7903872 Cyclic-GMP-mediated decrease in permeability of human umbilical and pulmonary artery endothelial cell monolayers. 1994 Jan-Feb 1
27 1309828 Thrombin inhibits proliferation of the human megakaryoblastic MEG-01 cell line: a possible involvement of a cyclic-AMP dependent mechanism. 1992 Jan 1
28 1331412 Potentiation of cyclic adenosine monophosphate production by thrombin in the human erythroleukemia cell line, HEL. 1992 Nov 1
29 1333990 Thrombin-induced proliferation and expression of platelet-derived growth factor-A chain gene in human vascular smooth muscle cells. 1992 Dec 14 1
30 1375452 Cyclic AMP does not inhibit collagen-induced platelet signal transduction. 1992 May 1 1
31 1651428 [Intracellular Ca2+ mobilization and its regulation in platelet activation]. 1991 May 1
32 1710933 Protein kinase C and cyclic AMP modulate thrombin-induced platelet-activating factor synthesis in human endothelial cells. 1991 Jun 7 1
33 2475104 Cleavage of a 100 kDa membrane protein (aggregin) during thrombin-induced platelet aggregation is mediated by the high affinity thrombin receptors. 1989 Aug 15 1
34 3372537 Transcriptional regulation of the A and B chain genes of platelet-derived growth factor in microvascular endothelial cells. 1988 Jun 15 1
35 3040721 Agents that increase cAMP accumulation block endothelial c-sis induction by thrombin and transforming growth factor-beta. 1987 Sep 5 1
36 2943273 The influence of activating hormones on human platelet membrane Ca2+-ATPase activity. 1986 Jul 16 1
37 2410292 Inhibition by forskolin of cytosolic calcium rise, shape change and aggregation in quin2-loaded human platelets. 1985 Aug 19 1
38 6091292 Effects of dibutyryl cyclic AMP and forskolin on phospholipid biosynthesis in thrombin-stimulated human platelets. 1984 Sep 1 2
39 6091624 Effects of prostaglandin I2 and forskolin on the secretion from platelets evoked at basal concentrations of cytoplasmic free calcium by thrombin, collagen, phorbol ester and exogenous diacylglycerol. 1984 Sep 15 3
40 6329175 Cytoplasmic Ca2+ in platelets is controlled by cyclic AMP: antagonism between stimulators and inhibitors of adenylate cyclase. 1984 Apr 30 1
41 6088107 Effects of diterpene forskolin on the release reaction and protein phosphorylation of human platelets. 1983 Oct 1
42 6571835 Reversal of thrombin-induced myosin phosphorylation and the assembly of cytoskeletal structures in platelets by the adenylate cyclase stimulants prostaglandin D2 and forskolin. 1983 Jan 25 3